Q1 2024 SenesTech Inc Earnings Call
Operator: Good day and welcome to the Senestech, Inc. first quarter fiscal year 2024 financial results conference call. All participants will be in a listen-only mode.
Good day and welcome to the Sonesta, Inc. Reports first quarter fiscal year 2024 financial results Conference call.
Operator: All participants will be in a listen only mode should you need assistance. Please signal a conference specialist by pressing the star key followed by zero.
Operator: Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your touchtone phone.
Operator: After todays presentation, there will be an opportunity to ask questions to ask a question you May Press Star then one on your Touchtone phone.
Operator: Please note, this event is being recorded. I would now like to turn the conference over to Robert Blum of Litham Partners. Please go ahead. All right, thank you.
Operator: Please note this event is being recorded.
Operator: I would now like to turn the conference over to Robert Blum with Lytham Partners. Please go ahead.
Robert A. Blum: All right. Thank you very much, Chad. And thank you to everyone for joining us on today's call. As the operator indicated in its first quarter 2024 financial results for the period ended March 31, 2024. With us on the call today are Mr. Joel Fruendt, the company's chief executive officer, and Mr. Tom Chesterman, the company's chief financial officer. At the conclusion of today's prepared remarks, we will open the call for a question and answer session.
Robert A. Blum: Alright, Thank you very much Chad and thank you to everyone for joining us on today's call as the operator indicated, forcing US teck's first quarter 2020 for financial results for the period ended March 31, 2024 with us on the call today are Mr. Joel front, the company's Chief Executive Officer, Mr. Tom Chubb.
Robert A. Blum: German the company's Chief financial Officer at the conclusion of today's prepared remarks, we will open the call for a question and answer session.
Robert A. Blum: As the operator indicated, if you dialed in to the call through the traditional teleconference line and you'd like to ask a question, again, please press star 1 to ask the question. If you are listening through the webcast portal and would like to ask a question, you can submit your question through the Ask a Question feature in the webcast player. We'll do our best to get to as many questions as possible.
Robert A. Blum: As the operator indicated if you dialed in to the call through the traditional teleconference line.
Robert A. Blum: And you'd like to ask a question again. Please press star one to ask a question. If you are listening through the webcast portal and would like to ask a question you can submit your questions through the ask a question feature in the webcast player will do our best to get to as many questions as possible before.
Robert A. Blum: Before we begin with prepared remarks, we submit for the record the following statement. Statements made by the management team of Senestech during the course of this conference call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
Robert A. Blum: Before we begin with prepared remarks, we submit for the record the following statement.
Robert A. Blum: Statements made by the management team up so that's tech during the course of this conference call may contain forward looking statements within the meaning of section 27 eight of the Securities acts 1933, as amended and section 21 E of the Securities Exchange Act of 1934 as amended and such forward looking statements are made pursuant to the safe Harbor provisions of the <unk>.
Robert A. Blum: Forward-looking statements describe future expectations, plans, results, or strategies and are generally preceded by words such as may, future, plan or planned, will or should, expected anticipates, draft eventually, or projected. Listeners are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risk that actual results may differ materially from those projected in the forward-looking statements as a result of various factors and other risks identified in the company's filings with the Securities Exchange Commission.
Robert A. Blum: Private Securities Litigation Reform Act of 1995 forward looking statements describe future expectations plans results or strategies and are generally preceded by words, such as may future plan or planned will or should expected anticipates a draft eventually or projected listeners are cautioned.
Robert A. Blum: And that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances events or results to differ materially from those projected in the forward looking statements, including the risks that actual results may differ materially from those projected in the forward looking statements as a result of various factors and other risks identified in the company's filings with the security exchange.
Robert A. Blum: Commission all forward looking statements contained during this conference call speak only as of the date in which they were made and are based on management's assumptions and estimates as of such date.
Robert A. Blum: All forward-looking statements contained in this conference call speak only of the date in which they were made and are based on management's assumptions and estimates as of such date. The company does not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events, or otherwise. With that said, let me turn the call over to Joel Fruendt, Chief Executive Officer of Senestech. Joel, please proceed.
Joel Fruendt: Company does not undertake any obligation to publicly update any forward looking statements whether as a result of the receipt of new information the occurrence of future events or otherwise with that said, let me turn the call over to Joel front, Chief Executive Officer for Snapback Joel. Please proceed.
Joel Fruendt: Thank you, Robert. Good afternoon, everyone.
Joel Fruendt: Thank you Robert.
Joel Fruendt: Afternoon, everyone.
Joel Fruendt: Thank you for joining us today for our Q1 conference call. I certainly couldn't be more pleased to be speaking with you today, given all the positive developments going on with the company. So, let me jump right into it.
Joel Fruendt: Thank you for joining us today for our Q1 conference call.
Joel Fruendt: I certainly couldn't be more pleased to be speaking with you today given all the positive developments going on with the company. So let me jump right into it.
Joel Fruendt: During the first quarter, we reported record revenue of $415,000, an increase of 78% compared to the first quarter of last year. This was also a 41% increase sequentially from the fourth quarter of 2023. The key driver has been the introduction of Evalve, our all new softbait product launched in January of this year, which has quickly become the company's biggest selling product, contributing more than 50% of first quarter revenue. As a reminder, Evolve is an EPA-designated minimum risk product and brings three key benefits to the marketplace.
Joel Fruendt: During the first quarter, we reported record revenue of $415000, an increase of 78% compared to the first quarter of last year.
Joel Fruendt: It was also a 41% increase sequentially from the fourth quarter of 2023.
Joel Fruendt: Key driver has been the introduction of evolve our all new sulfate product launched in January of this year.
Joel Fruendt: Has quickly become the company's biggest selling product contributing more than 50% of first quarter revenue.
Joel Fruendt: As a reminder, evolve as an E P. A designated minimum risk product and brings three key benefits to the marketplace. One a shelf life of one year plus so it is an excellent rodent control product for distribution.
Joel Fruendt: One, it has a shelf life of one year plus, so it is an excellent rodent control product for distribution. Two, it is delivered in a sophate form factor, so it is familiar and easy to use in the field. And three, it is economical and is offered at a competitive price to traditional rodenticides. I'll come back to this more in a moment.
Joel Fruendt: Two it is delivered in a software form factor. So it is familiar and easy to use in the field.
Joel Fruendt: And three it is economical and is offered at a competitive price to traditional rodenticides.
Joel Fruendt: I'll come back to this more in a moment.
Joel Fruendt: One point to make regarding revenues; this outstanding growth reflected regulatory approval of Evolve in only 30 states. There were several states, including high potential states such as Florida, that required an efficacy study before approval. That efficacy study is now complete, which bodes well for acceptance by the remaining states and further accelerated growth in Q2. Speaking of the efficacy study, we finished up our study at the University of Arizona last month, and the results were positive, as expected and predicted from the literature available on the active ingredient and from our experience with Contrapest. The study results confirmed a 61% reduction in litter size through only one breeding cycle.
Joel Fruendt: One point to make regarding the revenues this outstanding growth reflect the regulatory approval of evolve and only 30 states.
Joel Fruendt: There are several states, including high potential states, such as Florida are required an efficacy study before approval.
Joel Fruendt: That efficacy study is now complete which bodes well for acceptance by the remaining states and further accelerated growth in Q2.
Joel Fruendt: Speaking of the efficacy study we finished up our study at the University of Arizona last month.
Joel Fruendt: And the results were positive as expected and predicted from the literature available on the active ingredient and from our experience with Contra pest.
Joel Fruendt: The study results confirmed a 61% reduction in litter size through only one breeding cycle.
Joel Fruendt: This indicates an 85% reduction in population over six months compared to leaving the population untreated, and 90% plus after one year. We will now start some longer-term field trials at customer locations, and we fully expect the efficacy to increase significantly over multiple litters with increased consumption and in real world conditions. This is actually a little better than our first short-term study with contrapep, which then went on to prove over 90% efficacy in longer-term field studies.
Joel Fruendt: Indicates an 85% reduction in population over six months compared to leaving the population of untreated and 90% plus after one year.
Joel Fruendt: We will now start some longer term field trials at customer locations and we fully expect the efficacy they increased significantly over multiple letters with increased consumption and with real world conditions.
Joel Fruendt: This is actually a little better than our first short term study with Contra pest, which then went on to prove out over 90% efficacy and longer term field studies.
Joel Fruendt: We expect Evolve will prove to be the product of choice for rodent population control. With this published report, we now have the data requested by certain state and international regulators, increasing the conversion potential for the rest of this year. Another key highlight was our introduction of Evolve Mouse this month. This product utilizes the same revolutionary breakthrough fertility solution as you vow only to control mouse infestations, effectively doubling our addressable market opportunities.
Joel Fruendt: We expect the Bob will prove to be the product of choice for road and population control.
Joel Fruendt: With this published report we now have the data requested by certain state and international regulators.
Joel Fruendt: <unk> the conversion potential for the rest of this year.
Joel Fruendt: Another key highlight was our introduction that revolve mouse this month.
Joel Fruendt: The South Bay.
Joel Fruendt: Product utilizes the same revolutionary breakthrough fertility solution Nancy ball.
Joel Fruendt: Only to control mouse infestation, effectively doubling our addressable market opportunity.
Joel Fruendt: One of our lead distributors and online retailers, DIY Pest Control, has already committed to a sizable pre-order, and we'll immediately add Evolve Mouse to their website. Product shipments began last week, and we expect Evolve Mouse to be a key driver of growth throughout the rest of the year. This effectively doubles our addressable market opportunity. It has been estimated that U.S. rodent pest management product sales, over half of which target mouse infestations, are more than $1 billion annually and are growing.
Joel Fruendt: One of our lead distributors and online retailers DIY pest control, that's already committed to a sizeable preorder.
Joel Fruendt: And we will immediately add evolve miles to their website offerings.
Joel Fruendt: Product shipments began last week.
Joel Fruendt: And we expect evolved mouse to be a key driver to growth throughout the rest of the year.
Joel Fruendt: This effectively doubles, our addressable market opportunity. It has been estimated that U S Road in pest management product sales over half of which target mouse infestations are more than 1 billion annually and are growing.
Joel Fruendt: At the same time, regulators in California and other areas are putting more restrictions on the application of commonly used poisons, leading consumers and pest managers to seek new methods for control and ease of purchase options, providing us with an enhanced opportunity going forward.
Joel Fruendt: At the same time, the regulators in California, and other areas or putting more restrictions on the application of the family and will you use poisons, leading consumers in pest managers to seek new methods for control and ease of purchase options, providing us with an enhanced opportunity going forward.
Joel Fruendt: Evolve has proven to be a very versatile product that is perfect for many distribution channels that focus on our target market. To keep focusing on each of these areas, we have developed our six-channel strategy for distribution. Our six channels are e-commerce, international, agribusiness, pest management, industrial, and retail. We have strategies designed for each channel, and I will briefly comment on progress in each channel. In the e-commerce space, we have expanded the offerings on our own site significantly.
Joel Fruendt: Hey, Bob has proven to be a very personal product is perfect for many distribution channels.
Joel Fruendt: Focus on our target markets.
Joel Fruendt: To keep focus on each of these areas, we have developed our sixth channel strategy for distribution.
Joel Fruendt: Our six six channels our E Commerce International.
Joel Fruendt: Group business Pest management industrial and retail.
Joel Fruendt: We have strategies designed for each channel.
Joel Fruendt: I will briefly comment on progress in each channel.
Joel Fruendt: In the ecommerce space, we have expanded the offerings on their own site significantly.
Joel Fruendt: We're also proud to announce the launch of a dedicated Amazon store, which we launched this week. This was really made possible by the introduction of EVAL and by the expansion of our packaging from the initial 6-pound and 12-pound pail sizes that are so popular with the professional market to now include 1.5-pound and 3-pound pouches that are more convenient for the consumer market, as well as being more Earth-friendly with their packaging.
Joel Fruendt: We're also proud to announce the launch of a dedicated Amazon store, which we have launched this week.
Joel Fruendt: This was really made possible by the introduction of the ball by the expansion of our packaging from the initial six pound and 12 pounds payroll sizes that are so popular with the professional market.
Joel Fruendt: I'll include 1.5 pounds, a three pound pouches that are more convenient for the consumer market as.
Joel Fruendt: As well as being worth more earth friendly with their packaging.
Joel Fruendt: The International Channel has seen substantial interest and activity. Since EVAL's launch, we have signed six key international exclusive distribution agreements, from Hong Kong to Australia to the UAE. Each of the agreements requires an initial order of a full pallet minimum, around $10,000.
Joel Fruendt: The International Channel has seen substantial interest in activity since evolves launch we obtained six key international exclusive distribution agreements from.
Joel Fruendt: From Hong Kong to Australia to the U a E.
Joel Fruendt: Each of the agreements requires an initial order of a full pallet minimum.
Joel Fruendt: $10000.
Joel Fruendt: And the annual sales minimum starts at $100,000 for exclusive distribution rights and grows over time. In our agribusiness channel, we announced a new agreement with Wilco Distributing, who placed a multi-pallet stocking order, addressing some very lucrative open field agriculture opportunities. This followed agreements with Poppy Enterprises for the Grain Management Area and Agricon for the Ag Production and Protein Production Facilities Management. In the Pest Management Channel, we have signed agreements and have initial stocking orders from Deseres, where there are 77 locations, and DIY Pest Control to satisfy demand from their significant pest control customer base.
Joel Fruendt: And the annual sales minimums started $100000 for exclusive distribution rights and grow over time.
Joel Fruendt: And our agribusiness channel, we announced a new angry a new agreement with Wilco distributing.
Joel Fruendt: Who placed a multi pallet stocking order addressing some very lucrative open field agriculture opportunities.
Joel Fruendt: This followed the agreements with Poppy enterprises for the grain management area and agro com for the egg production and protein production facilities management.
Joel Fruendt: In the Pest management channel, we have signed agreements and have initial stocking orders from the Saracen there are 77 locations.
Joel Fruendt: In DIY pest control to satisfy demand from their significant pest control customer base.
Joel Fruendt: Our commitment by our field staff. The pest management market, pest control operators, and government agencies are creating a pull-through effect where local availability in distributors' warehouses is a key factor in driving revenue growth. We have identified a significant opportunity in the industrial channel and are finalizing agreements for an industrial rep agency with 28 outside sales reps to assist us in getting your biostock at substantial industrial distributors such as Grainger and Fasenal. This will be our channel to reach the facilities management and food safety markets as well. We expect this agreement to be completed soon.
Joel Fruendt: Our commitment by our field staff.
Joel Fruendt: The pest management market pest control operators and government agencies is creating a pull through effect, where local availability and distributors' warehouses is a key factor in driving revenue growth.
Joel Fruendt: We have identified a significant opportunity and opportunity in the industrial channel.
Joel Fruendt: And are finalizing agreements for an industrial Rep agency with 28 outside sales reps to assist us in getting your ball stopped it.
Joel Fruendt: Substantial industrial distributors, such as Grainger and pass it all.
Joel Fruendt: This will be our channel to reach the facilities management and food safety markets as well.
Joel Fruendt: We expect this agreement to be completed soon.
Joel Fruendt: And, as we talked about during our year-end call, we are excited about the opportunities in the retail channel. Since we received approval as a vendor for a national hardware retailer, which consists of over 4,500 locations, we have now completed the process of getting set up in their system with our Evolve product. We have also signed on to attend their August market days to display our products for purchase by local store managers and owners.
Joel Fruendt: And as we talked about during our year end call. We are excited about the opportunities in the retail channel.
Joel Fruendt: Since we received approval as a vendor for a national hardware retailer.
Joel Fruendt: Which consists of over 4500 locations.
Joel Fruendt: We have now completed the process of getting set up in their system.
Joel Fruendt: With the heart valve products.
Joel Fruendt: We have also signed on to attend their August market days to display our products for purchase by local patient managers and owners.
Joel Fruendt: To enhance our presence and fully address that network and other similar retailers, we have signed a rep agency with over 30 field reps to represent us with these major national and regional retailers in home supply, hardware, and ag retail locations. This will be a key sales driver for us in 2024. Using distribution channels to leverage and extend our sales reach is a key initiative for the year, and we are off to a great start. You can expect further news in the coming months as we further penetrate the retail and warehouse club network.
Joel Fruendt: To enhance our presence and fully address that networks and other similar retailers. We have signed a rep agency with over 30 field reps to represent US with these major national and regional retailers and home supply hardware and AG retail locations.
Joel Fruendt: This will be a key sales driver across it in 2024.
Joel Fruendt: Using distribution channels to leverage and extend our sales reach is a key initiative for the year and we're off to a great start.
Joel Fruendt: You can expect further news in the coming months as we further penetrate the retail and warehouse club networks.
Joel Fruendt: Finally, and as I assume most of you saw in the news, the New York City Council introduced a proposal for the deployment of EPA-approved birth control to address rodent infestation. Senestech is the only manufacturer of commercially available EPA-registered rat birth control, which we believe bodes well for our opportunity. Well, New York City is not at all the only urban market for us.
Joel Fruendt: Finally, and as I assume most of you saw on the news in New York City Council introduced or proposal for deployment. The EPA approved birth control to address rodent infestations.
Joel Fruendt: The NASDAQ is the only manufacturer of commercially available E. P. A registered rep birth control, which we believe bodes well for our opportunity.
Joel Fruendt: Well, New York City is not at all be on the urban market for US. It was a highly visible one and one that we will pursue after try home remedies dry ice grounding buckets another improvement tools.
Joel Fruendt: It is a highly visible one, and one that we will pursue. After trying home remedies, dry ice, drowning buckets, and other improvement tools, it is good to see that the city is finally looking at tested and proven techniques. To wrap up, I firmly believe the tide has shifted for Senestech. We have the right product solutions to address one of the world's most challenging problems, rodent control, in a completely different way than has ever been done before, by addressing the root cause of the problem, reproduction, and how to proactively control that reproduction.
Joel Fruendt: Good to see that the city has finally looking a tested and proven techniques.
Joel Fruendt: To wrap up I firmly believe the tide has shifted personnel that we have.
Joel Fruendt: Right product solutions to address one of the world's most challenging problems and control.
Joel Fruendt: Through a completely different way than has ever been done before by addressing the root cause of the problem reproduction and how to proactively control that reproduction.
Joel Fruendt: Our product lines, ContraPest and Evolve, address the fundamental issue of rodent overpopulation by proactively controlling the population rather than trying to keep up with the growing numbers of an infestation with poisons or traps alone. Remember, two rafts can turn into 15,000 in one year alone; you just can't kill them fast enough. In fact, during this call, there will be tens of thousands of rats born across the globe. Pest management professionals and homeowners are seeking alternatives to poisons as poisons are highly regulated and are tricky to use, plus poisons are less than 40% effective. Clearly, the development has evolved as a game changer for them and for us as well. To give you more detail on that and on the financials, let me turn the call over to Tom. Tom said,
Joel Fruendt: Our product lines Contra person he ball address the fundamental issue of blood and overpopulation by proactively controlling the population.
Tom: Rather than trying to keep up with the growing numbers of an infestation with poisons or traps alone.
Tom: Remember two rats can turn into 15000 in one year alone.
Tom: You just can't kill them fast enough okay.
Tom: In fact during this call there it'll be tens of thousand rats for Must've globe.
Tom: Pest management professionals and homeowners are seeking alternatives to poison as poisons are highly regulated and are tricky to use.
Tom: Poisons are less than 40% effective.
Tom: Clearly the development of Bob as a game changer for them and for us as well.
Joel Fruendt: Give me more detail on that and on the financials, Let me turn the call over to Tom Tom.
Thomas C. Chesterman: A reminder to our investors, the press release is available on our website in the investor relations section, as will be a recording of this presentation. Furthermore, we expect to file our 10-Q later today, so I will just touch on some of the high points right now. Revenue during the first quarter was $415,000, an increase of 78% compared to $233,000 in Q1 of 2023. As Joel mentioned, the key driver was Evolve, which represented more than 50% of our first quarter sales.
Tom: Thank you Joel.
Tom: A reminder to our investors. The press release is available on our website in the Investor Relations section as we will be a recording of this presentation.
Thomas C. Chesterman: Further we expect to file our 10-Q later today, so I will just touch on some of the high points right now.
Thomas C. Chesterman: Revenue during the first quarter was $415000, an increase of 78% compared to 233000.
Thomas C. Chesterman: In Q1 of 2023.
Thomas C. Chesterman: As Joel mentioned, the key driver was evolved which represented more than 50% of our first quarter sales.
Thomas C. Chesterman: Looking at it by our distribution verticals, we saw a significant increase in sales to test management professionals as well as commercial customers. I mentioned this last quarter, but I'll remind everyone again that due to the success of EVOLVE, we have had to expand our manufacturing capability. Today we have the capacity for about 1,000 pounds per day, soon to be 2,000 pounds, with a clear path to 4,000 pounds per day, more than enough to keep up with the current demand. At this point, Evolve is offered in 6- and 12-pound pails, which are optimal for the professional market, and 1.5-pound and 3-pound pouches for the consumer market, which we began shipping in March.
Thomas C. Chesterman: Looking at it by our distribution verticals, we saw a significant increase in sales pest management professionals as well as commercial customers.
Thomas C. Chesterman: I mentioned this last quarter, but I'll remind everyone again that due to the success of these all we have had to expand our manufacturing capabilities.
Thomas C. Chesterman: Today, we have the capacity for about 1000 pounds per day soon to be 2000 pounds with a clear path to 4000 pounds per day more than enough to keep up with the current demand.
Thomas C. Chesterman: At this point if all these offered in six and 12 town pills, which are optimal for the professional market and 1.5 pound and three pound patches for the consumer market, which we began shipping in March.
Thomas C. Chesterman: To allow for the increase in raw materials and finished goods, we've expanded our warehouse space in Phoenix. However, cost of sales in the first quarter of 2024 was impacted by the higher cost of the key ingredient in our new evolved product due to a supply chain issue. We corrected this issue as quickly as possible, but we were forced to use higher-cost ingredients in the first months of production. We finished that transition at the end of the first quarter.
Thomas C. Chesterman: To allow for the increase of raw materials and finished goods, we've expanded our warehouse space in Phoenix.
Thomas C. Chesterman: Cost of sales in the first quarter of 2024 was impacted by the higher cost of a key ingredient in our new evolve product due to a supply chain issue.
Thomas C. Chesterman: We corrected this issue as quickly as possible, but we were forced to use higher cost ingredients in the first months of production.
Thomas C. Chesterman: We finished that transition at the end of the first quarter.
Thomas C. Chesterman: To give you an example of the impact, if we had used the intended raw materials during the first quarter, which we are now, our gross profit would have been 52%. And as immediate confirmation, our preliminary gross margin in April was 58%. Going forward, we now have a reliable supply chain process, which will ensure that this does not recur.
Thomas C. Chesterman: To give you an example of the impact if we had used the intended raw materials during the first quarter, which we are now.
Thomas C. Chesterman: Our gross profit would've been 52%.
Thomas C. Chesterman: And as immediate confirmation or preliminary gross margin in April was 58%.
Thomas C. Chesterman: Going forward, we now have a reliable supply chain process, which will ensure that this does not recur.
Thomas C. Chesterman: Ultimately, whereas Contra Fest brings in a gross margin of about 50%, Evolve has the potential to earn 60% or more. Operating expenses for the quarter were $2 million, a decrease of 8% compared to the $2.1 million in the comparable period of 2023. We made numerous changes in our operating structure.
Thomas C. Chesterman: Ultimately, whereas contract as it brings in a gross margin of about 50%. If all has the potential to earn 60% or more.
Thomas C. Chesterman: Operating expenses for the quarter were $2 million, a decrease of 8% compared to the $2 1 million in the comparable period of 2023.
Thomas C. Chesterman: We made numerous changes in our operating structure.
Thomas C. Chesterman: The company remains committed to driving operational efficiencies with a goal of removing another million dollars out of annual operating expenses in 2024. The net loss during the quarter was $1.8 million compared to a net loss of $2 million in Q1 of 2023, an improvement of $200,000. Adjusted EBITDA loss, which is a non-gap measure of operating performance, for Q1 of 2024 was 1.7 million compared to 1.8 million in Q1 of 2023. The quarterly adjusted EBITDA loss was the smallest in company history as we strive to achieve our goal of achieving positive operating cash flow.
Thomas C. Chesterman: The company remains committed to driving operational efficiencies with a goal of removing another million dollars out of annual operating expenses in 2024.
Thomas C. Chesterman: Net loss during the quarter was $1 8 million compared to a net loss of $2 million in Q1 of 2023, an improvement of $200000.
Thomas C. Chesterman: Adjusted EBITDA loss, which is a non-GAAP measure of operating performance.
Thomas C. Chesterman: Q1 of 2024 was $1 7 million compared to $1 8 million in Q1 of 2023.
Thomas C. Chesterman: Quarterly adjusted EBITDA loss was the smallest in company history, as we strive to achieve our goal of achieving positive operating cash flow.
Thomas C. Chesterman: Cash at the end of the quarter was $3.6 million. We have approximately 3.1 million shorter-term warrants still outstanding after the last financing, and we are optimistic that as we continue to execute our business plan, the remaining warrants will be a source of cash over the coming quarters.
Thomas C. Chesterman: Cash at the end of the quarter was $3 $6 million.
Thomas C. Chesterman: We have approximately $3 1 million of shorter term warrants still outstanding after the last financing and.
Thomas C. Chesterman: And we are optimistic that as we continue to execute our business plan that the remaining warrants will be a source of cash over the coming quarters.
Operator: With that, Chad, please let me turn it over to you for questions. Thank you very much. We will now begin our questions
Thomas C. Chesterman: With that Chad. Please let me turn it over to you for questions. Thank you very much we will now begin our question and answer session to ask a question you May Press Star then one on your Touchtone phone twist.
Operator: Thank you very much. We will now begin our question and answer session. To ask a question, you may press star then 1 on your touchtone phone. To withdraw your question, please press star then 2. Again, pressing star then 1 will allow you to ask a question. At this time, we will pause momentarily to assemble our roster. And again, if you'd like to ask a question, please press star then 1.
Operator: To withdraw your question. Please press Star then two.
Operator: Again pressing star then one wall allow you to ask a question and at this time, we will pause momentarily to assemble our roster.
Operator: Okay.
Operator: And again, if you'd like to ask a question. Please press Star then one.
Robert A. Blum: Chad, this is Robert. I'll go ahead and jump in while we see if anyone comes in on the dial in and ask some questions through the website. Again, to anyone listening on the webcast, feel free to type your question in through the prompt box, the question prompt box, there on the webcast player. Joel and Tom, we have a question here. In terms of your sales outlook for the mouse product, what should we expect in the coming quarter here?
Operator: Chad This is Robert I'll go ahead and jumping while we see if anyone comes in on the dial in and ask some questions through the website I got into anyone listening on the webcast feel free to type your question in.
Robert A. Blum: The the prompt the question prompt box there on the webcast player Joel and Tom are we have a question here in terms of your sales outlook for the mouse product what should we expect in the coming quarter here.
Robert A. Blum: Yeah.
Joel Fruendt: So, as with our first Evolve product, there are certain states which accept the EPA minimum risk designation right away, and other states which will have additional questions or requirements. This may go more quickly than our first product, but we should assume that Evolve Mouse will gain state approval gradually and will build up to a good portion of our Evolve sales, probably in the 15 to 25 percent range, over the course of the year.
Robert A. Blum: So as with our first evolved product there are certain states, which accept the E. P. A minimum risk designation right away and other states, which will have additional questions or requirements.
Joel Fruendt: This may go more quickly and then our first product, but we should assume bad evolved mouthful gains state approval gradually and we'll build up to a good portion of our evolved sales probably in the 15% to 25% range over the course of the year.
Speaker Change: Okay, Great again, just as a reminder, if you want to ask a question through the live Star then one again through the webcast go ahead type it in it looks like we have one more question here do you expect the Amazon store two cannibalized sales from your own website or do you think it's a different customer.
Robert A. Blum: Okay, great. Again, just as a reminder, if you want to ask a question through the live feed, just star at one. Again, through the webcast, go ahead and type it in. It looks like we have one more question here. Do you expect the Amazon store to cannibalize sales from your own website, or do you think it's a different customer?
Robert A. Blum: Yeah.
Joel Fruendt: We have some great customers on our site, and I'm sure they will continue to purchase there. Amazon's a powerful channel, and there may well be many customers that prefer it, but there are also many customers out there that still prefer to deal directly with the company. So in any case, whether they wanna buy on our site or buy from Amazon, our pricing strategy is somewhat neutral. So we just believe that the power of the Amazon channel is gonna really come on strong.
Robert A. Blum: We have some great customers on our site and I am sure. They will continue to purchase their Amazon's a powerful channel and there may well be many customers that prefer it.
Joel Fruendt: But there are also many customers out there that preferred to steel deal directly with the company. So.
Joel Fruendt: In any case, whether they want to buy on our site or buying Amazon their pricing.
Joel Fruendt: Strategy is somewhat neutral neutral so.
Joel Fruendt: We just believe that the power of the Amazon channel is going to really come on strong.
Robert A. Blum: All right, fantastic. It looks like we have another question here. What will it take to get a distribution agreement with a major pest control company?
Speaker Change: Alright fantastic it looks like we have.
Robert A. Blum: Another question here, what will it take to get a distribution agreement with the major pest control companies.
Joel Fruendt: So we're in contact with the major pest control companies, and we do have some of their locations that are using it. So we think that as we get further along here with EVOLVE and it's proven out in the field, the pest control companies, along with the distribution companies that service the pest control, are going to be willing to take a look at some type of supply agreement going forward. We're really confident in that.
Robert A. Blum: So were in contact with the major pest control companies and we do have some of their locations that are using it.
Robert A. Blum: Okay, great. Looks like we don't have any further questions here, so Joel, I'll go ahead and turn it over to you for any closing comments.
Joel Fruendt: Thanks, Robert. Thank you all for your attention here today. This is shaping up to be an outstanding year for Senestech, and I look forward to sharing our success with you in the coming months. Thank you. The conference has now concluded. Thank you for attending.
Joel Fruendt: So.
Operator: The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.
Music: ?? ?? ??
Joel Fruendt: Think that as we get further along here with the ball and it's proven out in the field are.
Music: That pest control companies, along with the distribution companies that service the pest control major companies are going to be I'm willing to take a look at some type of supply agreement going forward.
Music: Really confident in that.
Robert: Okay, Great looks like are we don't have any further questions here. So Joel I'll go ahead and turn it over to you for any closing comments.
Music: Thanks Robert.
Music: Thank you all for your attention here today. This is shaping up to be an outstanding year for sonesta and I look forward to sharing our success with you in the coming months. Thank you.
Music: <unk>.
Music: The conference has now concluded.
Music: Thank you for attending today's presentation you may now disconnect.
Music: [music].